Gazette.govt.nzPursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Mirtazapine |
| Active Ingredient: | Mirtazapine 30mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Noumed Pharmaceuticals Limited |
| Manufacturer: | Fourrts India Laboratories Pvt Limited, Chennai, India |
|
This consent is valid for two years from the date of publication of this notice. This consent is given subject to the following condition:
|
|
| Product: | Mirtazapine |
| Active Ingredient: | Mirtazapine 45mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Noumed Pharmaceuticals Limited |
| Manufacturer: | Fourrts India Laboratories Pvt Limited, Chennai, India |
|
This consent is valid for two years from the date of publication of this notice. This consent is given subject to the following condition:
|
|
Dated this 12th day of August 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).